Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Zhu, Chunxiao, Guan, Xiaoqing, Zhang, Xinuo, Luan, Xin, Song, Zhengbo, Cheng, Xiangdong, Zhang, Weidong, Qin, Jiang-Jiang
Published in Molecular cancer (04.08.2022)
Published in Molecular cancer (04.08.2022)
Get full text
Journal Article
Large-scale targeted metabolomics method for metabolite profiling of human samples
Cao, Guodong, Song, Zhengbo, Hong, Yanjun, Yang, Zhiyi, Song, Yuanyuan, Chen, Zhongjian, Chen, Zhaobin, Cai, Zongwei
Published in Analytica chimica acta (15.08.2020)
Published in Analytica chimica acta (15.08.2020)
Get full text
Journal Article
Machine learning applied to near-infrared spectra for clinical pleural effusion classification
Chen, Zhongjian, Chen, Keke, Lou, Yan, Zhu, Jing, Mao, Weimin, Song, Zhengbo
Published in Scientific reports (03.05.2021)
Published in Scientific reports (03.05.2021)
Get full text
Journal Article
Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-β degradation
Shen, Yingying, Lu, Chaojie, Song, Zhengbo, Qiao, Chenxiao, Wang, Jiaoli, Chen, Jinbiao, Zhang, Chengyan, Zeng, Xianchang, Ma, Zeyu, Chen, Tao, Li, Xu, Lin, Aifu, Guo, Jufeng, Wang, Jianli, Cai, Zhijian
Published in Nature communications (14.06.2022)
Published in Nature communications (14.06.2022)
Get full text
Journal Article
Identification of Deleterious NOTCH Mutation as Novel Predictor to Efficacious Immunotherapy in NSCLC
Zhang, Kai, Hong, Xiaohua, Song, Zhengbo, Xu, Yu, Li, Chengcheng, Wang, Guoqiang, Zhang, Yuzi, Zhao, Xiaochen, Zhao, Zhengyi, Zhao, Jing, Huang, Mengli, Huang, Depei, Qi, Chuang, Gao, Chan, Cai, Shangli, Gu, Feifei, Hu, Yue, Xu, Chunwei, Wang, Wenxian, Lou, Zhenkun, Zhang, Yong, Liu, Li
Published in Clinical cancer research (15.07.2020)
Published in Clinical cancer research (15.07.2020)
Get full text
Journal Article
The deep learning model combining CT image and clinicopathological information for predicting ALK fusion status and response to ALK-TKI therapy in non-small cell lung cancer patients
Song, Zhengbo, Liu, Tianchi, Shi, Lei, Yu, Zongyang, Shen, Qing, Xu, Mengdi, Huang, Zhangzhou, Cai, Zhijian, Wang, Wenxian, Xu, Chunwei, Sun, Jingjing, Chen, Ming
Published in European journal of nuclear medicine and molecular imaging (01.02.2021)
Published in European journal of nuclear medicine and molecular imaging (01.02.2021)
Get full text
Journal Article
Genomic profiles and tumor immune microenvironment of primary lung carcinoma and brain oligo-metastasis
Song, Zhengbo, Yang, Ling, Zhou, Zhipeng, Li, Pansong, Wang, Wenxian, Cheng, Guoping, Chen, Rongrong, Chang, Lianpeng, Zhang, Yiping, Guan, Yanfang, Xia, Xuefeng, Yi, Xin, Zhou, Rongrong, Chen, Ming
Published in Cell death & disease (21.01.2021)
Published in Cell death & disease (21.01.2021)
Get full text
Journal Article
Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
Shen, Yingying, Song, Zhengbo, Lu, Xinliang, Ma, Zeyu, Lu, Chaojie, Zhang, Bei, Chen, Yinghu, Duan, Meng, Apetoh, Lionel, Li, Xu, Guo, Jufeng, Miao, Ying, Zhang, Gensheng, Yang, Diya, Cai, Zhijian, Wang, Jianli
Published in Nature communications (02.07.2019)
Published in Nature communications (02.07.2019)
Get full text
Journal Article
Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung
Song, Zhengbo, Liu, Yueping, Cheng, Guoping, Chang, Lianpeng, Yu, Zicheng, Chen, Ming, Chen, Gang
Published in Cell death & disease (12.05.2021)
Published in Cell death & disease (12.05.2021)
Get full text
Journal Article
Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study
Wang, Wenxian, Wang, Hong, Lu, Peihua, Yu, Zongyang, Xu, Chunwei, Zhuang, Wu, Song, Zhengbo
Published in Journal of translational medicine (21.02.2019)
Published in Journal of translational medicine (21.02.2019)
Get full text
Journal Article
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
Wang, Wenxian, Shao, Lan, Xu, Yibing, Song, Zhengbo, Lou, Guangyuan, Zhang, Yiping, Chen, Ming
Published in BMC pulmonary medicine (06.05.2022)
Published in BMC pulmonary medicine (06.05.2022)
Get full text
Journal Article
Pyrotinib combined with thalidomide in advanced non-small-cell lung cancer patients harboring HER2 exon 20 insertions (PRIDE): protocol of an open-label, single-arm phase II trial
Ai, Xinghao, Song, Zhengbo, Jian, Hong, Zhou, Zhen, Chen, Zhiwei, Yu, Yongfeng, Li, Ziming, Lu, Shun
Published in BMC cancer (16.09.2021)
Published in BMC cancer (16.09.2021)
Get full text
Journal Article
Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations
Si, Jinfei, Hao, Yue, Wei, Jingwen, Xiang, Jing, Xu, Chunwei, Shen, Qiuping, Song, Zhengbo
Published in BMC pulmonary medicine (05.05.2023)
Published in BMC pulmonary medicine (05.05.2023)
Get full text
Journal Article
Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: a retrospective study
Gu, Xiaodong, Shi, Zhiyong, Shao, Lan, Zhang, Yuxin, Zhang, Yiping, Song, Zhengbo, Wang, Wenxian, Lou, Guangyuan
Published in BMC cancer (24.05.2022)
Published in BMC cancer (24.05.2022)
Get full text
Journal Article
Efficacy and safety of pyrotinib in advanced lung adenocarcinoma with HER2 mutations: a multicenter, single-arm, phase II trial
Song, Zhengbo, Li, Yuping, Chen, Shiqing, Ying, Shenpeng, Xu, Shuguang, Huang, Jianjin, Wu, Dan, Lv, Dongqing, Bei, Ting, Liu, Shuxun, Huang, Xiaoping, Xie, Congying, Wu, Xiaoyu, Fu, Jianfei, Hua, Feng, Wang, Wenxian, Xu, Chunwei, Gao, Chan, Cai, Shangli, Lu, Shun, Zhang, Yiping
Published in BMC medicine (01.02.2022)
Published in BMC medicine (01.02.2022)
Get full text
Journal Article
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trial
Song, Zhengbo, Lou, Guangyuan, Wang, Yina, Yang, Zhiping, Wang, Wenxian, Ji, Yongling, Chen, Shiqing, Xu, Chunwei, Hu, Xiao, Zhang, Yiping
Published in BMC medicine (10.05.2022)
Published in BMC medicine (10.05.2022)
Get full text
Journal Article
Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study
Zhang, Yongchang, Zhang, Xiangyu, Zhang, Ruiguang, Xu, Qinqin, Yang, Haiyan, Lizaso, Analyn, Xu, Chunwei, Liu, Jun, Wang, Wenxian, Ou, Sai-Hong Ignatius, Zhang, Jiexia, Song, Zhengbo, Yang, Nong
Published in BMC medicine (13.09.2021)
Published in BMC medicine (13.09.2021)
Get full text
Journal Article